Dashboard
1
The company has declared Positive results for the last 10 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 2,979.1 MM
- ROCE(HY) Highest at 15.87%
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
2
With ROE of 12.41%, it has a fair valuation with a 6.06 Price to Book Value
3
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
CNY 36,267 Million (Large Cap)
49.00
NA
0.21%
-0.29
13.71%
6.15
Revenue and Profits:
Net Sales:
78 Million
(Quarterly Results - Dec 2025)
Net Profit:
2,549 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.11%
0%
-11.11%
6 Months
2.96%
0%
2.96%
1 Year
114.69%
0%
114.69%
2 Years
137.17%
0%
137.17%
3 Years
274.02%
0%
274.02%
4 Years
233.92%
0%
233.92%
5 Years
217.8%
0%
217.8%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.28%
EBIT Growth (5y)
23.94%
EBIT to Interest (avg)
22.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.22
Tax Ratio
4.65%
Dividend Payout Ratio
10.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.47%
ROE (avg)
3.89%
Valuation key factors
Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
6.06
EV to EBIT
150.53
EV to EBITDA
94.69
EV to Capital Employed
10.31
EV to Sales
25.96
PEG Ratio
NA
Dividend Yield
0.22%
ROCE (Latest)
6.85%
ROE (Latest)
12.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
77.60
254.20
-69.47%
Operating Profit (PBDIT) excl Other Income
2,871.00
35.90
7,897.21%
Interest
0.00
0.30
-100.00%
Exceptional Items
0.00
19.50
-100.00%
Consolidate Net Profit
2,549.00
468.60
443.96%
Operating Profit Margin (Excl OI)
37,011.00%
17.30%
3,699.37%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -69.47% vs -10.30% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 443.96% vs 264.67% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,193.60
1,190.20
0.29%
Operating Profit (PBDIT) excl Other Income
3,293.30
334.50
884.54%
Interest
0.00
1.40
-100.00%
Exceptional Items
0.00
28.90
-100.00%
Consolidate Net Profit
2,938.70
691.40
325.04%
Operating Profit Margin (Excl OI)
2,759.20%
173.60%
258.56%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.29% vs 17.75% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 325.04% vs 143.97% in Dec 2024
About Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






